Faculty discussion - How heart failure biomarkers change clinical practice in the management of acute heart failure.
Session:
How heart failure biomarkers change clinical practice in the management of acute heart failure
Topic:
Acute Heart Failure
Speaker:
Professor A. Mebazaa (Paris, FR)
Professor H. Brunner-La Rocca (Maastricht, NL)
Doctor H. Gaggin (Boston, US)
Professor D. Logeart (Paris, FR)
Professor R. Troughton (Christchurch, NZ)
Sponsored by Roche Diagnostics
Event:
Heart Failure 2019
Congress Presentation
About the speakers
Professor Alexandre Mebazaa
Hospital Lariboisiere, Paris (France)
81
presentations
20
followers
Professor Hans-Peter Brunner-La Rocca
Maastricht University Medical Centre (MUMC), Maastricht (Netherlands (The))
16
presentations
2
followers
Doctor Hanna Gaggin
Massachusetts General Hospital, Boston (United States of America)
2
presentations
0
follower
Professor Damien Logeart
Hospital Lariboisiere, Paris (France)
6
presentations
1
follower
Professor Richard Troughton
University of Otago Christchurch, Christchurch (New Zealand)
2
presentations
0
follower
3 more presentations in this session
Role of NT-proBNP in acute heart failure diagnosis and treatment.
Speaker: Doctor H. Gaggin (Boston, US)
Physiologic differences between BNP and NT-proBNP and impact on clinical practice.
Speaker: Professor D. Logeart (Paris, FR)
Optimization of post-discharge management after acute heart failure.
Speaker: Professor R. Troughton (Christchurch, NZ)
Access the full session
How heart failure biomarkers change clinical practice in the management of acute heart failure
Speakers:
Professor A. Mebazaa, Professor H. Brunner-La Rocca, Doctor H. Gaggin, Professor D. Logeart, Professor R. Troughton...
About the event
ESC 365 is supported by
